Loading…
Sectoral / Thematic · Nippon India Mutual Fund · AMFI code 102431Nippon India Pharma Fund
Disclosed for 84 months, Sep 2019 to Aug 2026.Published as: NIPPON INDIA PHARMA FUND (An Open Ended Equity Scheme Investing In Pharma Sector)
Portfolio value
₹4,516 Cr
down ₹335 Cr vs Apr 2022
- Stocks held
- 27
- unchanged
- Top 10 weight
- 69.9%
- of the portfolio in its ten largest
- Cash & debt
- 1.7%
- cash, money market and debt
- Moves this month
- 0 in · 0 out
- added to 8, trimmed 18
Nippon India Pharma Fund is an active equity fund in the Sectoral / Thematic category from Nippon India Mutual Fund. In May 2022 it disclosed 27 stocks worth ₹4,516 Cr, down ₹335 Cr from Apr 2022. Its largest positions were Sun Pharmaceutical Industries Limited (13.9%), Cipla Limited (9.2%), Dr. Reddy's Laboratories Limited (7.7%); the ten largest together made up 69.9% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 79.9% of its equity. Cash and debt stood at 1.7%. Compared with Apr 2022 the fund entered 0 new stocks and exited 0.
Against 226 other Sectoral / Thematic funds
Concentration
95%
Top-10 weight is higher than 95% of peers
Breadth
10%
Holds more stocks than 10% of peers
Cash
26%
Holds more cash than 26% of peers
Holdings in May 2022
Download CSVEvery line the fund disclosed, with the change against Apr 2022. Click a column to sort; click a company to see every fund that owns it.
- Weight
- 13.91%
- Δ weight
- down 0.06 pts
- Value
- ₹628 Cr
- Δ value
- down ₹49.7 Cr
- Status
- Trimmed
- Weight
- 9.23%
- Δ weight
- up 0.74 pts
- Value
- ₹417 Cr
- Δ value
- up ₹4.9 Cr
- Status
- Added
- Weight
- 7.74%
- Δ weight
- up 0.43 pts
- Value
- ₹350 Cr
- Δ value
- down ₹5 Cr
- Status
- Trimmed
- Weight
- 6.89%
- Δ weight
- down 1.00 pts
- Value
- ₹311 Cr
- Δ value
- down ₹71.6 Cr
- Status
- Trimmed
- Weight
- 6.63%
- Δ weight
- up 0.50 pts
- Value
- ₹300 Cr
- Δ value
- up ₹1.9 Cr
- Status
- Added
- Weight
- 6.00%
- Δ weight
- up 0.03 pts
- Value
- ₹271 Cr
- Δ value
- down ₹18.8 Cr
- Status
- Trimmed
- Weight
- 5.89%
- Δ weight
- down 0.71 pts
- Value
- ₹266 Cr
- Δ value
- down ₹54.2 Cr
- Status
- Trimmed
- Weight
- 5.86%
- Δ weight
- up 0.84 pts
- Value
- ₹265 Cr
- Δ value
- up ₹21.2 Cr
- Status
- Added
- Weight
- 4.11%
- Δ weight
- down 0.42 pts
- Value
- ₹186 Cr
- Δ value
- down ₹34.4 Cr
- Status
- Trimmed
- Weight
- 3.61%
- Δ weight
- down 0.16 pts
- Value
- ₹163 Cr
- Δ value
- down ₹19.9 Cr
- Status
- Trimmed
- Weight
- 3.49%
- Δ weight
- up 0.18 pts
- Value
- ₹158 Cr
- Δ value
- down ₹3.1 Cr
- Status
- Trimmed
- Weight
- 3.17%
- Δ weight
- down 0.13 pts
- Value
- ₹143 Cr
- Δ value
- down ₹17 Cr
- Status
- Trimmed
- Weight
- 3.05%
- Δ weight
- up 0.05 pts
- Value
- ₹138 Cr
- Δ value
- down ₹7.9 Cr
- Status
- Trimmed
- Weight
- 2.65%
- Δ weight
- down 1.03 pts
- Value
- ₹120 Cr
- Δ value
- down ₹58.8 Cr
- Status
- Trimmed
- Weight
- 2.58%
- Δ weight
- down 0.37 pts
- Value
- ₹116 Cr
- Δ value
- down ₹26.7 Cr
- Status
- Trimmed
- Weight
- 2.56%
- Δ weight
- up 0.44 pts
- Value
- ₹116 Cr
- Δ value
- up ₹12.6 Cr
- Status
- Added
- Weight
- 2.09%
- Δ weight
- up 0.28 pts
- Value
- ₹94.6 Cr
- Δ value
- up ₹6.6 Cr
- Status
- Added
- Weight
- 1.77%
- Δ weight
- down <0.01 pts
- Value
- ₹79.8 Cr
- Δ value
- down ₹6.2 Cr
- Status
- Trimmed
- Cash, TREPS & receivables
- Weight
- 1.67%
- Δ weight
- up 0.33 pts
- Value
- ₹75.2 Cr
- Δ value
- up ₹10.7 Cr
- Status
- Added
- Weight
- 1.48%
- Δ weight
- up 0.23 pts
- Value
- ₹66.9 Cr
- Δ value
- up ₹6.1 Cr
- Status
- Added
- Weight
- 1.43%
- Δ weight
- down 0.25 pts
- Value
- ₹64.5 Cr
- Δ value
- down ₹16.8 Cr
- Status
- Trimmed
- Weight
- 0.79%
- Δ weight
- up 0.29 pts
- Value
- ₹35.6 Cr
- Δ value
- up ₹11.4 Cr
- Status
- Added
- Weight
- 0.73%
- Δ weight
- down 0.03 pts
- Value
- ₹32.8 Cr
- Δ value
- down ₹4 Cr
- Status
- Trimmed
- Weight
- 0.69%
- Δ weight
- down 0.06 pts
- Value
- ₹30.9 Cr
- Δ value
- down ₹5 Cr
- Status
- Trimmed
- Weight
- 0.61%
- Δ weight
- up 0.07 pts
- Value
- ₹27.5 Cr
- Δ value
- up ₹1.1 Cr
- Status
- Added
- Weight
- 0.58%
- Δ weight
- up 0.04 pts
- Value
- ₹26 Cr
- Δ value
- down ₹12 L
- Status
- Held
- Weight
- 0.47%
- Δ weight
- down 0.07 pts
- Value
- ₹21.1 Cr
- Δ value
- down ₹4.8 Cr
- Status
- Trimmed
- Weight
- 0.32%
- Δ weight
- down 0.14 pts
- Value
- ₹14.5 Cr
- Δ value
- down ₹8 Cr
- Status
- Trimmed
What changed, Apr 2022 to May 2022
New New positions (0)
None.
Exited Exited (0)
None.
Added Biggest additions
- Abbott India Limitedup ₹21.2 Cr (+0.84% pts)
- Pfizer Limitedup ₹12.6 Cr (+0.44% pts)
- Rainbow Childrens Medicare Limitedup ₹11.4 Cr (+0.29% pts)
- Zydus Lifesciences Limitedup ₹6.6 Cr (+0.28% pts)
- Alkem Laboratories Limitedup ₹6.1 Cr (+0.23% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Apr 2022, the weight rose most in Pharmaceuticals & Biotechnology (+1.5 pts), and fell most in Healthcare Services (−1.6 pts).
- Pharmaceuticals & Biotechnology78.4% → 79.9%+1.5 pts
- Healthcare Services19.3% → 17.7%−1.6 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | May 2021 | Nov 2021 | Feb 2022 | Apr 2022 | May 2022 |
|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 79.0% | 74.9% | 75.8% | 78.4% | 79.9% |
| Healthcare Services | 17.5% | 22.7% | 21.8% | 19.3% | 17.7% |
| Pharmaceuticals | 2.6% | 1.8% | 2.0% | 1.8% | 1.8% |
| Healthcare Equipment & Supplies | — | 0.6% | 0.5% | 0.6% | 0.6% |
Allocation in May 2022change vs Apr 2022
- Pharmaceuticals & Biotechnology (18)79.9%▲ 1.5 pts
- Healthcare Services (7)17.7%▼ 1.6 pts
- Pharmaceuticals (1)1.8%
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal.
Cash & debt, May 2022
1.7%
▲ 0.3 pts vs Apr 2022
- Cash alone
- 1.7%
- cash and net receivables
- A year earlier
- 5.9%
- May 2021 · now ▼ 4.2 pts
- Last 12 months
- 0.4% – 4.8%
- lowest to highest · record 5.9% in May 2021
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.